Innate immunity to Mycobacterium tuberculosis

被引:436
作者
van Crevel, R
Ottenhoff, THM
van der Meer, JWM
机构
[1] Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands
关键词
D O I
10.1128/CMR.15.2.294-309.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The different manifestations of infection with Mycobacterium tuberculosis reflect the balance between the bacillus and host defense mechanisms. Traditionally, protective immunity to tuberculosis has been ascribed to T-cell-mediated immunity, with CD4+ T cells playing a crucial role. Recent immunological and genetic studies support the long-standing notion that innate immunity is also relevant in tuberculosis. In this review, emphasis is on these natural, innate host defense mechanisms, referring to experimental data (e.g., studies in gene knockout mice) and epidemiological, immunological, and genetic studies in human tuberculosis. The first step in the innate host defense is cellular uptake of M. tuberculosis, which involves different cellular receptors and humoral factors. Toll-like receptors seem to play a crucial role in immune recognition of M. tuberculosis, which is the next step. The subsequent inflammatoty response is regulated by, production of pro- and anti-inflammatory cytokines and chemokines. Different natural effector mechanisms for killing of M. tuberculosis have now been identified. Finally, the innate host response is necessary, for induction of adaptive immunity to M. tuberculosis. These basic mechanisms augment our understanding of disease pathogenesis and clinical course and will be of help in designing adjunctive treatment strategies.
引用
收藏
页码:294 / +
页数:17
相关论文
共 260 条
[71]  
FRIEDLAND JS, 1995, CLIN EXP IMMUNOL, V100, P233
[72]  
Frucht DM, 1996, J IMMUNOL, V157, P411
[73]   Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumor necrosis factor-α, and interferon-γ in human monocytes infected with Mycobacterium tuberculosis H37Ra [J].
Fulton, SA ;
Cross, JV ;
Toossi, ZT ;
Boom, WH .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04) :1105-1114
[74]   Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis [J].
Fulton, SA ;
Johnsen, JM ;
Wolf, SF ;
Sieburth, DS ;
Boom, WH .
INFECTION AND IMMUNITY, 1996, 64 (07) :2523-2531
[75]  
García VE, 1999, J IMMUNOL, V162, P6114
[76]   Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics [J].
Garred, P ;
Richter, C ;
Andersen, AB ;
Madsen, HO ;
Mtoni, I ;
Svejgaard, A ;
Shao, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (02) :204-208
[77]  
GAYNOR CD, 1995, J IMMUNOL, V155, P5343
[78]   Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans [J].
Geluk, A ;
van Meijgaarden, KE ;
Franken, KLMC ;
Drijfhout, JW ;
D'Souza, S ;
Necker, A ;
Huygen, K ;
Ottenhoff, THM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6463-6471
[79]   DEFECTIVE ANTIGEN PRESENTATION BY MYCOBACTERIUM TUBERCULOSIS-INFECTED MONOCYTES [J].
GERCKEN, J ;
PRYJMA, J ;
ERNST, M ;
FLAD, HD .
INFECTION AND IMMUNITY, 1994, 62 (08) :3472-3478
[80]   CD4+ T cell clones producing both interferon-γ and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients [J].
Gerosa, F ;
Nisii, C ;
Righetti, S ;
Micciolo, R ;
Marchesini, M ;
Cazzadori, A ;
Trinchieri, G .
CLINICAL IMMUNOLOGY, 1999, 92 (03) :224-234